Research Article

Early Changes in [18F]FDG Uptake as a Readout for PI3K/Akt/mTOR Targeted Drugs in HER-2-Positive Cancer Xenografts

Figure 3

In vivo longitudinal imaging study of JIMT1 and SKOV3 xenografts. Graphic representation of tumor growth curves and relative [18F]FDG SUVmax at day 2 and day 7 of treatment for (a, c, e) JIMT1 and (b, d, f) SKOV3 xenografts.